{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:48:00Z","timestamp":1780087680899,"version":"3.54.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/npp.2012.18","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T11:31:24Z","timestamp":1330515084000},"page":"1717-1728","source":"Crossref","is-referenced-by-count":32,"title":["Effects of Sustained Administration of Quetiapine Alone and in Combination with a Serotonin Reuptake Inhibitor on Norepinephrine and Serotonin Transmission"],"prefix":"10.1038","volume":"37","author":[{"given":"Olga","family":"Chernoloz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"El Mansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"BFnpp201218_CR1","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1523\/JNEUROSCI.02-12-01786.1982","volume":"2","author":"GK Aghajanian","year":"1982","unstructured":"Aghajanian GK, Vandermaelen CP (1982a). Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J Neurosci 2: 1786\u20131792.","journal-title":"J Neurosci"},{"key":"BFnpp201218_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/30.8.6749973","volume":"30","author":"GK Aghajanian","year":"1982","unstructured":"Aghajanian GK, Vandermaelen CP (1982b). Intracellular recording in vivo from serotonergic neurons in the rat dorsal raphe nucleus: Methodological considerations. J Histochem Cytochem 30: 813\u2013814.","journal-title":"J Histochem Cytochem"},{"key":"BFnpp201218_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1523\/JNEUROSCI.11-03-00760.1991","volume":"11","author":"G Aston-Jones","year":"1991","unstructured":"Aston-Jones G, Akaoka H, Charlety P, Chouvet G (1991). Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11: 760\u2013769.","journal-title":"J Neurosci"},{"key":"BFnpp201218_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4088\/JCP.08m04629","volume":"70","author":"M Bauer","year":"2009","unstructured":"Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M (2009). Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: Results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry 70: 540\u2013549.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 8","key":"BFnpp201218_CR5","first-page":"30","volume":"66","author":"P Blier","year":"2005","unstructured":"Blier P, Szabo ST (2005). Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. J Clin Psychiatry 66 (Suppl 8): 30\u201340.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201218_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2010.06.031","volume":"128","author":"B Bortnick","year":"2011","unstructured":"Bortnick B, El-Khalili N, Banov M, Adson D, Datto C, Raines S et al (2011). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study. J Affect Disord 128: 83\u201394.","journal-title":"J Affect Disord"},{"key":"BFnpp201218_CR7","first-page":"252","volume":"29","author":"P Celada","year":"2004","unstructured":"Celada P, Puig MV, Amarg\u00f3s-Bosch M, Adell A, Artigas F (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29: 252\u2013265.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp201218_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-244X-8-73","volume":"8","author":"Y Chaput","year":"2008","unstructured":"Chaput Y, Magnan A, Gendron A (2008). The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial. BMC Psychiatry 8: 73.","journal-title":"BMC Psychiatry"},{"key":"BFnpp201218_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/475027a","volume":"475","author":"PY Collins","year":"2011","unstructured":"Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS (2011). Grand challenges in global mental health. Nature 475: 27\u201330.","journal-title":"Nature"},{"key":"BFnpp201218_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0014-2999(92)90772-V","volume":"221","author":"O Curet","year":"1992","unstructured":"Curet O, De Montigny C, Blier P (1992). Effect of desipramine and amphetamine on noradrenergic neurotransmission: Electrophysiological studies in the rat brain. Eur J Pharmacol 221: 59\u201370.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201218_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4088\/JCP.08m04592","volume":"70","author":"AJ Cutler","year":"2009","unstructured":"Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Astr\u00f6m M, Brecher M (2009). Extended release quetiapine fumarate monotherapy in major depressive disorder: A placebo- and duloxetine-controlled study. J Clin Psychiatry 70: 526\u2013539.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201218_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0006-8993(80)90927-0","volume":"200","author":"C De Montigny","year":"1980","unstructured":"De Montigny C, Wang RY, Reader TA, Aghajanian GK (1980). Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 200: 363\u2013376.","journal-title":"Brain Res"},{"key":"BFnpp201218_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2165\/00023210-200923050-00002","volume":"23","author":"C DeBattista","year":"2009","unstructured":"DeBattista C, Hawkins J (2009). Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 23: 369\u2013377.","journal-title":"CNS Drugs"},{"key":"BFnpp201218_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.biopsych.2006.05.015","volume":"61","author":"E Dremencov","year":"2007","unstructured":"Dremencov E, El Mansari M, Blier P (2007a). Noradrenergic augmentation of escitalopram response by risperidone: Electrophysiologic studies in the rat brain. Biol Psychiatry 61: 671\u2013678.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201218_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00213-007-0818-8","volume":"194","author":"E Dremencov","year":"2007","unstructured":"Dremencov E, El Mansari M, Blier P (2007b). Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons. Psychopharmacology 194: 63\u201372.","journal-title":"Psychopharmacology"},{"key":"BFnpp201218_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.npp.1300686","volume":"30","author":"M El Mansari","year":"2005","unstructured":"El Mansari M, S\u00e1nchez C, Chouvet G, Renaud B, Haddjeri N (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: An in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30: 1269\u20131277.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201218_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1017\/S1461145710000015","volume":"13","author":"N El-Khalili","year":"2010","unstructured":"El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P et al (2010). Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: A multicentre, randomized, double-blind, placebo-controlled study. Int J Neuropsychopharmacol 13: 917\u2013932.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201218_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-2999(82)90605-7","volume":"81","author":"AL Frankhuyzen","year":"1982","unstructured":"Frankhuyzen AL, Mulder AH (1982). Pharmacological characterization of presynaptic \u03b1-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 81: 97\u2013106.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201218_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0014-2999(84)90618-6","volume":"105","author":"JE Freedman","year":"1984","unstructured":"Freedman JE, Aghajanian GK (1984). Idazoxan (RX 781094) selectively antagonizes \u03b12-adrenoceptors on rat central neurons. Eur J Pharmacol 105: 265\u2013272.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201218_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s002130050238","volume":"130","author":"SE Gartside","year":"1997","unstructured":"Gartside SE, Umbers V, Sharp T (1997). Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitos:R studies on the role of 5-HT(1A) autoreceptors and noradrenergic mechanisms. Psychopharmacology 130: 261\u2013268.","journal-title":"Psychopharmacology"},{"key":"BFnpp201218_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-011-2260-1","volume":"217","author":"R Ghanbari","year":"2011","unstructured":"Ghanbari R, El Mansari M, Blier P (2011). Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology (Berl) 217: 61\u201373.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201218_CR22","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1176\/appi.ajp.159.10.1702","volume":"159","author":"ML Gilmor","year":"2002","unstructured":"Gilmor ML, Owens MJ, Nemeroff CB (2002). Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. Am J Psychiatry 159: 1702\u20131710.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201218_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1527-3458.1995.tb00276.x","volume":"1","author":"JM Goldstein","year":"1995","unstructured":"Goldstein JM, Arvanitis LA (1995). ICI 204,636 (seroquel): A dibenzothiazepine atypical antipsychotic. review of preclinical pharmacology and highlights of phase II clinical trials. CNS Drug Rev 1: 50\u201373.","journal-title":"CNS Drug Rev"},{"key":"BFnpp201218_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0165-0327(98)00223-7","volume":"51","author":"N Haddjeri","year":"1998","unstructured":"Haddjeri N, Blier P, De Montigny C (1998a). Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J Affect Disord 51: 255\u2013266.","journal-title":"J Affect Disord"},{"key":"BFnpp201218_CR25","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998","volume":"18","author":"N Haddjeri","year":"1998","unstructured":"Haddjeri N, Blier P, De Montigny C (1998b). Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT(1A) receptors. J Neurosci 18: 10150\u201310156.","journal-title":"J Neurosci"},{"key":"BFnpp201218_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-2999(00)00173-4","volume":"395","author":"K-I Hatanaka","year":"2000","unstructured":"Hatanaka K-I, Yatsugi S-I, Yamaguchi T (2000). Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex. Eur J Pharmacol 395: 31\u201336.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201218_CR27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/sj.bjp.0701561","volume":"122","author":"P Hertel","year":"1997","unstructured":"Hertel P, Nomikos GG, Svensson TH (1997). Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. Br J Pharmacol 122: 1639\u20131646.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201218_CR28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0028-3908(99)00045-3","volume":"38","author":"P Hertel","year":"1999","unstructured":"Hertel P, Nomikos GG, Svensson TH (1999). The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex. Neuropharmacology 38: 1175\u20131184.","journal-title":"Neuropharmacology"},{"key":"BFnpp201218_CR29","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","volume":"33","author":"NH Jensen","year":"2008","unstructured":"Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL (2008). N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology 33: 2303\u20132312.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201218_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/jn.1961.24.3.243","volume":"24","author":"ER Kandel","year":"1961","unstructured":"Kandel ER, Spencer WA (1961). Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 24: 243\u2013259.","journal-title":"J Neurophysiol"},{"key":"BFnpp201218_CR31","first-page":"23","volume":"6","author":"S Kasper","year":"2010","unstructured":"Kasper S, Pail G (2010). Milnacipran: a unique antidepressant? Neuropsychiatr Dis Treat 6: 23\u201331.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFnpp201218_CR32","unstructured":"Katila H, Mezhebovsky I, Mulroy A (2008). Efficacy and tolerability of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD). 8th International Forum on Mood and Anxiety Disorders."},{"key":"BFnpp201218_CR33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0022-3565(25)24669-9","volume":"257","author":"D Lacroix","year":"1991","unstructured":"Lacroix D, Blier P, Curet O, De Montigny C (1991). Effects of long-term desipramine administration on noradrenergic neurotransmission: Electrophysiological studies in the rat brain. J Pharmacol Exp Ther 257: 1081\u20131090.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201218_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/da.20740","volume":"27","author":"M Liebowitz","year":"2010","unstructured":"Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H (2010). Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: A randomized, placebo-controlled trial. Depress Anxiety 27: 964\u2013976.","journal-title":"Depress Anxiety"},{"key":"BFnpp201218_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","volume":"40","author":"C Lindsay DeVane","year":"2001","unstructured":"Lindsay DeVane C (2001). Clinical pharmacokinetics of quetiapine: An atypical antipsychotic. Clin Pharmacokinet 40: 509\u2013522.","journal-title":"Clin Pharmacokinet"},{"key":"BFnpp201218_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1476-5381.1992.tb14450.x","volume":"106","author":"NJ Mallard","year":"1992","unstructured":"Mallard NJ, Hudson AL, Nutt DJ (1992). Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Br J Pharmacol 106: 1019\u20131027.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201218_CR37","first-page":"272","volume":"34","author":"S Manta","year":"2009","unstructured":"Manta S, Dong J, Debonnel G, Blier P (2009). Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J Psychiatry Neurosci 34: 272\u2013280.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp201218_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0014-2999(85)90173-6","volume":"116","author":"G Maura","year":"1985","unstructured":"Maura G, Gemignani A, Raiteri M (1985). \u03b12-adrenoceptors in rat hypothalamus and cerebral cortex: Functional evidence for pharmacologically distinct subpopulations. Eur J Pharmacol 116: 335\u2013339.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201218_CR39","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1517\/13543784.2010.538048","volume":"19","author":"SL McElroy","year":"2010","unstructured":"McElroy SL, Guerdjikova A, Mori N, Keck Jr PE (2010). Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opin Investig Drugs 19: 1527\u20131544.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFnpp201218_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/da.20275","volume":"24","author":"A McIntyre","year":"2007","unstructured":"McIntyre A, Gendron A, McIntyre A (2007). Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study. Depress Anxiety 24: 487\u2013494.","journal-title":"Depress Anxiety"},{"key":"BFnpp201218_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF00167444","volume":"347","author":"R Mongeau","year":"1993","unstructured":"Mongeau R, Blier P, De Montigny C (1993). In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of \u03b12-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 347: 266\u2013272.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFnpp201218_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/npp.1994.6","volume":"10","author":"R Mongeau","year":"1994","unstructured":"Mongeau R, De Montigny C, Blier P (1994). Electrophysiologic evidence for desensitization of \u03b12-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10: 41\u201351.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201218_CR43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","volume":"166","author":"JC Nelson","year":"2009","unstructured":"Nelson JC, Papakostas GI (2009). Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 166: 980\u2013991.","journal-title":"Am J Psychiatry"},{"issue":"SUPPL 8","key":"BFnpp201218_CR44","first-page":"13","volume":"66","author":"CB Nemeroff","year":"2005","unstructured":"Nemeroff CB (2005). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry 66 (SUPPL 8): 13\u201321.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl E1","key":"BFnpp201218_CR45","first-page":"4","volume":"69","author":"DJ Nutt","year":"2008","unstructured":"Nutt DJ (2008). Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69 (Suppl E1): 4\u20137.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201218_CR46","first-page":"209","volume":"6","author":"GI Papakostas","year":"2005","unstructured":"Papakostas GI (2005). Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. Essent Psychopharmacol 6: 209\u2013220.","journal-title":"Essent Psychopharmacol"},{"issue":"Suppl 6","key":"BFnpp201218_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4088\/JCP.8133su1c.03","volume":"70","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI (2009). Managing partial response or nonresponse: Switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 70 (Suppl 6): 16\u201325.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201218_CR48","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic press, 4th edition."},{"key":"BFnpp201218_CR49","doi-asserted-by":"crossref","unstructured":"Ranck JB (1975). Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats. In: Isaacson LR, editor. The hippocampus. New York: Plenum Press, 207\u2013244.","DOI":"10.1007\/978-1-4684-2979-4_7"},{"key":"BFnpp201218_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02245606","volume":"124","author":"A Schotte","year":"1996","unstructured":"Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Gompel P, Lesage AS et al (1996). Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 124: 57\u201373.","journal-title":"Psychopharmacology"},{"key":"BFnpp201218_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00213-005-2198-2","volume":"181","author":"MA Seager","year":"2005","unstructured":"Seager MA, Barth VN, Phebus LA, Rasmussen K (2005). Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: Implications for bipolar disorder. Psychopharmacology 181: 126\u2013133.","journal-title":"Psychopharmacology"},{"key":"BFnpp201218_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/11530280-000000000-00000","volume":"24","author":"RC Shelton","year":"2010","unstructured":"Shelton RC, Osuntokun O, Heinloth AN, Corya SA (2010). Therapeutic options for treatment-resistant depression. CNS Drugs 24: 131\u2013161.","journal-title":"CNS Drugs"},{"key":"BFnpp201218_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0893-133X(99)00057-3","volume":"21","author":"JS Sprouse","year":"1999","unstructured":"Sprouse JS, Reynolds LS, Braselton JP, Rollema H, Zorn SH (1999). Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: Inhibition of dorsal raphe cell firing and the role of 5-HT(1A) receptor activation. Neuropsychopharmacology 21: 622\u2013631.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201218_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1017\/S1092852900027334","volume":"15","author":"SM Stahl","year":"2010","unstructured":"Stahl SM (2010). Enhancing outcomes from major depression: Using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment. CNS Spectrums 15: 79\u201394.","journal-title":"CNS Spectrums"},{"key":"BFnpp201218_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00213-006-0621-y","volume":"190","author":"AD Stark","year":"2007","unstructured":"Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Mistry Kannan T et al (2007). Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: Functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology 190: 373\u2013382.","journal-title":"Psychopharmacology"},{"key":"BFnpp201218_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1461145700001772","volume":"3","author":"ST Szabo","year":"2000","unstructured":"Szabo ST, de Montigny C, Blier P (2000). Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol 3: 1\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201218_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/syn.10009","volume":"42","author":"ST Szabo","year":"2001","unstructured":"Szabo ST, Blier P (2001). Serotonin 1A receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABAA receptors: A microiontophoretic study in the rat locus coeruleus. Synapse 42: 203\u2013212.","journal-title":"Synapse"},{"key":"BFnpp201218_CR58","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1124\/jpet.102.033282","volume":"302","author":"ST Szabo","year":"2002","unstructured":"Szabo ST, Blier P (2002). Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT2a receptor antagonism on the firing activity of norepinephrine neurons. J Pharmacol Exp Ther 302: 983\u2013991.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201218_CR59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C et al (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 60: 1079\u20131088.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201218_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S1092852900020307","volume":"14","author":"R Weisler","year":"2009","unstructured":"Weisler R, Joyce JM, McGill L, Lazarus A, Szamosi J, Eriksson H (2009). Extended release quetiapine fumarate monotherapy for major depressive disorder: Results of a double-blind, randomized, placebo-controlled study. CNS Spectrums 14: 299\u2013313.","journal-title":"CNS Spectrums"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201218","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T06:08:17Z","timestamp":1742623697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFnpp201218"],"URL":"https:\/\/doi.org\/10.1038\/npp.2012.18","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}